HLB Life Science Co., Ltd. (067630.KQ)
KRW 6500.0
(3.17%)
KRW 6500.0
(3.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -748.57 Million KRW | 23.83% |
| 2022 | -4.56 Billion KRW | 27.41% |
| 2021 | -6.29 Billion KRW | -542.51% |
| 2020 | 1.42 Billion KRW | -76.73% |
| 2019 | 6.11 Billion KRW | 38.02% |
| 2018 | 4.42 Billion KRW | -13.28% |
| 2017 | 5.1 Billion KRW | 62.87% |
| 2016 | 3.13 Billion KRW | 162.63% |
| 2015 | -5 Billion KRW | -196.98% |
| 2014 | 5.16 Billion KRW | 2661.3% |
| 2013 | 186.94 Million KRW | -31.79% |
| 2012 | 274.06 Million KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -991.43 Million KRW | -256.45% |
| 2024 Q1 | -243.46 Million KRW | 87.42% |
| 2023 Q2 | -1.65 Billion KRW | -197.42% |
| 2023 Q4 | -1.93 Billion KRW | -21.88% |
| 2023 Q3 | -1.58 Billion KRW | 4.11% |
| 2023 FY | -3.47 Billion KRW | 23.83% |
| 2023 Q1 | 1.69 Billion KRW | 139.65% |
| 2022 Q2 | -1.63 Billion KRW | -172.46% |
| 2022 Q4 | -4.28 Billion KRW | -376.11% |
| 2022 Q3 | -900.49 Million KRW | 44.83% |
| 2022 FY | -4.56 Billion KRW | 27.41% |
| 2022 Q1 | 2.25 Billion KRW | 135.09% |
| 2021 Q2 | 40.1 Million KRW | 147.65% |
| 2021 Q4 | -6.41 Billion KRW | -3851.59% |
| 2021 Q1 | -84.15 Million KRW | -109.05% |
| 2021 Q3 | 171.09 Million KRW | 326.67% |
| 2021 FY | -6.29 Billion KRW | -542.51% |
| 2020 Q2 | 409.72 Million KRW | 43.91% |
| 2020 FY | 1.42 Billion KRW | -76.73% |
| 2020 Q4 | 929.86 Million KRW | 71.46% |
| 2020 Q3 | 542.33 Million KRW | 32.37% |
| 2020 Q1 | 284.7 Million KRW | -95.7% |
| 2019 Q3 | -1.53 Billion KRW | -386.13% |
| 2019 Q2 | 536.75 Million KRW | -69.22% |
| 2019 Q1 | 1.74 Billion KRW | 47.61% |
| 2019 FY | 6.11 Billion KRW | 38.02% |
| 2019 Q4 | 6.62 Billion KRW | 531.46% |
| 2018 Q4 | 1.18 Billion KRW | 3.44% |
| 2018 Q3 | 1.14 Billion KRW | 18.59% |
| 2018 Q2 | 963.17 Million KRW | -10.6% |
| 2018 Q1 | 1.07 Billion KRW | -45.21% |
| 2018 FY | 4.42 Billion KRW | -13.28% |
| 2017 Q1 | 936.98 Million KRW | -70.14% |
| 2017 Q3 | 1.01 Billion KRW | -21.73% |
| 2017 Q4 | 1.96 Billion KRW | 94.19% |
| 2017 Q2 | 1.29 Billion KRW | 38.08% |
| 2017 FY | 5.1 Billion KRW | 62.87% |
| 2016 Q3 | -260.87 Million KRW | -276.19% |
| 2016 Q4 | 3.13 Billion KRW | 1302.83% |
| 2016 FY | 3.13 Billion KRW | 162.63% |
| 2016 Q2 | 148.06 Million KRW | 22.69% |
| 2016 Q1 | 120.68 Million KRW | -56.48% |
| 2015 Q1 | -605.9 Million KRW | -125.62% |
| 2015 Q2 | -3.09 Billion KRW | -410.96% |
| 2015 Q4 | 277.27 Million KRW | 124.4% |
| 2015 Q3 | -1.13 Billion KRW | 63.29% |
| 2015 FY | -5 Billion KRW | -196.98% |
| 2014 Q1 | 589.8 Million KRW | 164.57% |
| 2014 Q2 | 1.06 Billion KRW | 81.38% |
| 2014 FY | 5.16 Billion KRW | 2661.3% |
| 2014 Q3 | 1.13 Billion KRW | 6.31% |
| 2014 Q4 | 2.36 Billion KRW | 107.95% |
| 2013 Q2 | 182.84 Million KRW | 1443.28% |
| 2013 Q3 | 905.72 Million KRW | 395.34% |
| 2013 Q4 | -913.47 Million KRW | -200.86% |
| 2013 FY | 186.94 Million KRW | -31.79% |
| 2013 Q1 | 11.84 Million KRW | -90.91% |
| 2012 Q3 | -42.78 Million KRW | 0.0% |
| 2012 FY | 274.06 Million KRW | 0.0% |
| 2012 Q4 | 130.41 Million KRW | 404.81% |
| Name | Gross Profit | Gross Profit Difference |
|---|